Clinical Relevance of Serum Galactose Deficient IgA1 in Patients with IgA Nephropathy

New biomarkers of IgA nephropathy (IgAN) are needed for non-invasive diagnosis and appropriate treatment. There is emerging evidence that galactose deficient IgA1 (Gd-IgA1) is a pivotal molecule in the pathogenesis of IgAN. However, few studies have investigated the role of Gd-IgA1 as a biomarker in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jin Sug, Hwang, Hyeon Seok, Lee, Sang Ho, Kim, Yang Gyun, Moon, Ju-Young, Kong, Ji Yoon, Jeong, Kyung Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694202/
https://www.ncbi.nlm.nih.gov/pubmed/33158064
http://dx.doi.org/10.3390/jcm9113549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694202/
https://www.ncbi.nlm.nih.gov/pubmed/33158064
http://dx.doi.org/10.3390/jcm9113549

Ejemplares similares